EUVIMEDEUVIMED entdecken
Crossref

Assisted reproductive technologies in Latin America: the Latin American Registry, 2021

Fernando Zegers-Hochschild, Javier A Crosby, Carolina Musri, Fanny Petermann-Rocha, Gustavo Martinez, Hitomi Nakagawa, Carlos Morente, Armando Roque, Ana Palma-Govea, Latin American Network of Assisted Reproduction

Reproductive BioMedicine Online · 2025

DOI: 10.1016/j.rbmo.2024.104413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2025. Verfasst von Fernando Zegers-Hochschild und 9 weiteren Autor:innen. Beteiligte Einrichtung: Program of Ethics and Public Policies in Human Reproduction, Faculty de Medicine, University Diego Portales, Santiago, Chile; Unit of Reproductive Me…. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: Ferring Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: What are the trends and impact of new technologies on the effectiveness and safety of assisted reproductive technology (ART) performed in Latin America during 2021? DESIGN: This was a retrospective collection of cycle-based multinational data obtained from ART procedures performed by 204 accredited institutions in 16 countries. RESULTS: In total 127,351initiated cycles resulted in 20,032 deliveries and 22,708 births. ART utilization showed great variability, from 623.5 cycles/million inhabitants in Uruguay to fewer than 35 in Guatemala and El Salvador. The proportion of women aged ≥40 years increased to 35.8%, while that of women ≤34 years dropped to 23.9%. Nonetheless, the proportion of single-embryo transfers (SET) increased from 11.9% in the previous decade to 42.4% in 2021. Of 22,708 babies born, 76.8% were singletons, 22.3% twins and 1.0% triplets or more. Intracytoplasmic sperm injection represented 84.5% of fertilization techniques, and blastocyst transfer increased from 49.6% in 2016 to 79.3% in 2021. The delivery rate after fresh blastocyst elective SET was significantly higher than after the transfer of one frozen embryo from a freeze-all cycle (P < 0.0001). The number of aspirations leading to preimplantation genetic testing has increased 2.8 times in 5 years and significantly increased delivery rates/transfer at all ages, including in oocyte donation (P ≤ 0.002), and reduced miscarriage in women ≥35 years old. In oocyte donation, delivery rates after the fresh transfer of embryos from vitrified-warmed oocyte cycles generated similar outcomes to frozen embryo transfer. Perinatal mortality increased from 7.7‰ in singletons to 21.3‰ in twins. CONCLUSION: The systematic collection of cycle-based multinational data contributes to cooperative sustained development and helps implement evidence-based reproductive decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reproductive Techniques, AssistedHumansLatin AmericaFemalePregnancyAdultRegistriesRetrospective StudiesEmbryo TransferPregnancy RatePregnancy Outcome

Stichwörter der Autor:innen

ART RegistryEmbryo aneuploidyOocyte donationPreimplantation genetic testingReproductive outcome

Autor:innen und Institutionen

  • Program of Ethics and Public Policies in Human Reproduction, Faculty de Medicine, University Diego Portales, Santiago, Chile; Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile. Electronic address: fzege…
  • Program of Ethics and Public Policies in Human Reproduction, Faculty de Medicine, University Diego Portales, Santiago, Chile; Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile.
  • Program of Ethics and Public Policies in Human Reproduction, Faculty de Medicine, University Diego Portales, Santiago, Chile; SG Fertility Chile, Chile.
  • Program of Ethics and Public Policies in Human Reproduction, Faculty de Medicine, University Diego Portales, Santiago, Chile.
  • Medicina Reproductiva Fertilis, San Isidro, Buenos Aires, and Universidad de Belgrano, Buenos Aires, Argentina.
  • GENESIS, Centro de Assistência em Raproduçãu Humana, Brasilia, Brazil.

Förderung

  • Ferring Pharmaceuticals

Zitieren

APA

Zegers-Hochschild, F., Crosby, J. A., Musri, C., Petermann-Rocha, F., Martinez, G., Nakagawa, H., Morente, C., Roque, A., Palma-Govea, A., & Latin American Network of Assisted Reproduction (2025). Assisted reproductive technologies in Latin America: the Latin American Registry, 2021. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2024.104413

Vancouver

Zegers-Hochschild F, Crosby JA, Musri C, Petermann-Rocha F, Martinez G, Nakagawa H, et al. Assisted reproductive technologies in Latin America: the Latin American Registry, 2021. Reproductive BioMedicine Online. 2025. doi:10.1016/j.rbmo.2024.104413

BibTeX
@article{ZegersHochschild2025,
  author = {Zegers-Hochschild, Fernando and Crosby, Javier A and Musri, Carolina and Petermann-Rocha, Fanny and Martinez, Gustavo and Nakagawa, Hitomi and Morente, Carlos and Roque, Armando and Palma-Govea, Ana and Latin American Network of Assisted Reproduction, Latin American Network of Assisted Reproduction},
  title = {Assisted reproductive technologies in Latin America: the Latin American Registry, 2021},
  journal = {Reproductive BioMedicine Online},
  year = {2025},
  doi = {10.1016/j.rbmo.2024.104413}
}
Kostenlos starten →